5/15/2018 9:46 AM
Shares of drug name Valeant Pharmaceuticals Intl Inc (NYSE:VRX) are trading higher this morning, after the stock received an upgrade from Mizuho to "buy" from "neutral" and a price-target hike to $27...
5/8/2018 11:56 AM
It's been a volatile day for stocks, with major equity indexes bouncing between positive and negative territory as investors anxiously await President Donald Trump's decision on whether or not to m...
5/7/2018 10:05 AM
Shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) are up 2.6% to trade at $18.49, after the Canada-based drugmaker said the Food and Drug Administration (FDA) had approved PLENVU -- a bowel clean...